Natural Capsules P/B Ratio
NATCAPSUQ • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
0.68
Low Valuation
Low - Trading below book value, may indicate undervaluation
Current Valuation Metrics
P/B Ratio
0.68
Current Price
₹151.00
Book Value/Share
₹257.00
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹257 Cr
Share Capital
₹10 Cr
Reserves & Surplus
₹223 Cr
Outstanding Shares
10,000,000
Book Value per Share
₹257.00
Valuation Signal
Signal
Undervalued
Historical Avg
2.29
Historical Range
0.65 - 4.33
Percentile
20.0%
Sector Context
Sector Average
-0.14
Sector Median
0.6
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Natural Capsules
- Stock appears undervalued with PB of 0.68, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 70.3% below historical average
- Trading at premium to sector average PB of -0.14
View the current stock price of Natural Capsules for more insights.
P/B Ratio Historical Trend for Natural Capsules
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Natural Capsules
Additional stock information and data for NATCAPSUQ
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.65 | ₹257.0 | ₹166.00 | ₹257 | Low |
| 2024 | 1.07 | ₹254.44 | ₹271.55 | ₹229 | Moderate |
| 2023 | 2.19 | ₹164.44 | ₹359.75 | ₹148 | Moderate |
| 2022 | 4.33 | ₹118.57 | ₹513.15 | ₹83 | High |
| 2021 | 3.21 | ₹103.33 | ₹331.50 | ₹62 | High |
Sector P/B Ratio Comparison
Comparing Natural Capsules with other companies in Healthcare sector
Sector Average
-0.14
Sector Median
0.6
Lowest P/B
-11.38
Highest P/B
1.1
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -11.38 | ₹4,036 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.67 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |